Abivax seeks shareholder approval for 10% cap on free share grants

• Abivax shareholders will vote May 11, 2026 on a board request to authorize grants of free shares, using existing shares or newly issued shares, to employees and eligible corporate officers across the group.
• Plan caps total awards at 10% of share capital outstanding on date board implements authorization, counting toward overall issuance limit referenced in Resolution 31.
• Authorization would run for 38 months, giving board flexibility to execute equity incentives over that period.
• Statutory auditors issued an unqualified view on the proposal’s disclosed terms, supporting a vote in favor.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abivax SA published the original content used to generate this news brief on April 20, 2026, and is solely responsible for the information contained therein.